EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diagnosis and Management of Visceral Leishmaniasis in Children: A French Retrospective Study

Justine de Larminat iD, Naïma Dahane, Nicolas Argy, Mahmoud Rifai, Olivier Haas Ferrua, Christelle Pomares, Nicolas Rasandisona Ravonjena, Damien Dupont iD, Jean-Philippe Lemoine, Sarah Dutron, Olivia Pineau, Philippe Picherit Steinbrucker und 8 weitere

Open Forum Infectious Diseases · 26.11.2025 · 12 (12)

DOI: 10.1093/ofid/ofaf708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 20.11.2025. Verfasst von Justine de Larminat und 19 weiteren Autor:innen. Beteiligte Einrichtung: General Pediatrics, Infectious Diseases and Internal Medicine, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Reference Center for Leishmaniasis in Montpellier, Santé Publique France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few studies have investigated the diagnosis and management of pediatric visceral leishmaniasis (VL) in high-income countries.

Methods

All children hospitalized for VL in university hospitals across mainland France between January 2012 and August 2022 were included in this retrospective study.

Results

Sixty-three patients were included with an M/F sex ratio of 1.25 and a median age of 2 years (IQR: 1; 5.4). At least 36 patients had autochthonous VL. The median delay between symptom onset and diagnosis was 20 days (IQR: 11.7; 35.2) [1–193]. The most common symptoms were fever (92%) and splenomegaly (78%). Biological findings included inflammatory syndrome (90%), pancytopenia (79%), and hepatic cytolysis (52%). Twenty-four children (44%) presented hemophagocytic lymphohistiocytosis (HLH). Bone marrow smears, bone marrow real-time PCR (qPCR), and blood qPCR were positive for VL in 64%, 90%, and 96% of the tested patients, respectively. Positivity reached 100% in patients who underwent combined blood and bone marrow PCR. All the patients were treated with liposomal amphotericin B (chemical name, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid;2-aminoguanidine). Ten different regimens were used, ranging from 18 to 30 mg/kg cumulative doses given from 2 to 8 days. The median follow-up duration was 2.8 months. Four patients (6.3%) relapsed, one of whom was not retreated. All the children recovered.

Conclusions

Pediatric VL remains rare in France, with long diagnostic delays and a high frequency of HLH. The combination of blood and bone marrow PCR optimizes the diagnosis. Standardization of therapeutic regimens and follow-up is necessary.

Schlagwörter

Stichwörter der Autor:innen

childrenhemophagocytic lymphohistiocytosisleishmaniasis PCRliposomal amphotericin Bvisceral leishmaniasis

Autor:innen und Institutionen

  • General Pediatrics, Infectious Diseases and Internal Medicine, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Parasitology, Mycology, and Tropical Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Parasitology and Mycology, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • IRDUMR 261-INSERM 1344 MERIT, Faculty of Pharmacy, Paris Cité University, Paris, France.
  • General Pediatrics, André Mignot Hospital, Le Chesnay, France.
  • Parasitology, Archet Site, University Hospital Center of Nice, Nice, France.

ORCID-Profile: Justine de Larminat, Damien Dupont

Förderung

  • National Reference Center for Leishmaniasis in Montpellier
  • Santé Publique France

Zitieren

APA

de Larminat, J., Dahane, N., Argy, N., Rifai, M., Ferrua, O. H., Pomares, C., Ravonjena, N. R., Dupont, D., Lemoine, J. P., Dutron, S., Pineau, O., Steinbrucker, P. P., César, T., Azohana, S., Guilmin-Crepon, S., Minodier, P., Allouche, I., Lorrot, M., Ravel, C., & Faye, A. (2025). Diagnosis and Management of Visceral Leishmaniasis in Children: A French Retrospective Study. Open Forum Infectious Diseases, 12(12). https://doi.org/10.1093/ofid/ofaf708

Vancouver

de Larminat J, Dahane N, Argy N, Rifai M, Ferrua OH, Pomares C, et al. Diagnosis and Management of Visceral Leishmaniasis in Children: A French Retrospective Study. Open Forum Infectious Diseases. 2025;12(12). doi:10.1093/ofid/ofaf708

BibTeX
@article{deLarminat2025,
  author = {de Larminat, Justine and Dahane, Naïma and Argy, Nicolas and Rifai, Mahmoud and Ferrua, Olivier Haas and Pomares, Christelle and Ravonjena, Nicolas Rasandisona and Dupont, Damien and Lemoine, Jean-Philippe and Dutron, Sarah and Pineau, Olivia and Steinbrucker, Philippe Picherit and César, Thibault and Azohana, Séhomi and Guilmin-Crepon, Sophie and Minodier, Philippe and Allouche, Irina and Lorrot, Mathie and Ravel, Christophe and Faye, Albert},
  title = {Diagnosis and Management of Visceral Leishmaniasis in Children: A French Retrospective Study},
  journal = {Open Forum Infectious Diseases},
  year = {2025},
  volume = {12},
  number = {12},
  doi = {10.1093/ofid/ofaf708}
}
Kostenlos starten →